Filing Details
- Accession Number:
- 0001405626-18-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-11 12:59:20
- Reporting Period:
- 2018-07-09
- Accepted Time:
- 2018-07-11 12:59:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1596062 | Q Biomed Inc. | QBIO | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1405626 | Denis Corin | 10 Market Street Suite 427 Grand Cayman E9 KY1-9006 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-07-09 | 7,000 | $3.37 | 2,448,800 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-07-10 | 7,000 | $2.85 | 2,441,800 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The Sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2018 for the sale of up to 139,871 shares of common stock. Such sales were outside the Reporting Person's investment decision.